Scandinavian ChemoTech AB (publ) Interim report Q3 January – September 2021 - Executive Summary of the third quarter
Third quarter · Net sales amounted to kSEK 9 (41) · Profit before tax amounted to kSEK -5 732 (-2 851) · Earnings per share amounted to SEK -0,65 (-0,47) · Cash flow from operating activities totaled to kSEK -7 014 (-2 836) Period 1 January - 30 September · Net sales amounted to kSEK 39 (131) · Profit before tax amounted to kSEK -12 313 (-8 872) · Earnings per share amounted to SEK -1,48 (-1,95) · Cash flow from operating activities totaled to kSEK -13 428 (-8 701) · The order book amounted to kSEK 1 100 (527) at the end of the period Important events